TCG Crossover Management, LLC
PALO ALTO, CA · CIK 1839948 · 13F filing filed 2023-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyPalo Alto, CA
$609.8m
reported value
+18.9% vs Q1 2023
22positions
80.7%in top 10
2 new
4 added
1 reduced
2 sold out
vs Q1 2023
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| IVERIC BIO INC OPHT | $96.3m15.80% | Reduced -2.7m |
| GERON CORP GERN | $75.7m12.42% | Added +5.8m |
| COGENT BIOSCIENCES INC COGT | $66.7m10.93% | Added +2.0m |
| VECTIVBIO HLDG AG ORD SHS | $52.9m8.68% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $37.8m6.19% | Added +1.1m |
| ICOSAVAX INC COM | $36.8m6.03% | New |
| MADRIGAL PHARMACEUTICALS INC MDGL | $34.6m5.68% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $33.9m5.56% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $30.6m5.01% | Unchanged |
| VENTYX BIOSCIENCES INC VTYX | $26.8m4.39% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $18.6m3.04% | Unchanged |
| KURA ONCOLOGY INC KURA | $15.1m2.47% | Unchanged |
| STRUCTURE THERAPEUTICS INC GPCR | $14.5m2.39% | Unchanged |
| IMMUNOVANT INC IMVT | $12.4m2.04% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $11.6m1.90% | Unchanged |
| AN2 THERAPEUTICS INC ANTX | $11.0m1.80% | New |
| ENTRADA THERAPEUTICS INC TRDA | $8.9m1.45% | Unchanged |
| MERUS N V MRUS | $7.9m1.30% | Unchanged |
| CABALETTA BIO INC CABA | $6.3m1.03% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $5.5m0.90% | Unchanged |
| C4 THERAPEUTICS INC CCCC | $3.5m0.58% | Added +26.6k |
| ALPINE IMMUNE SCIENCES INC NVLS | $2.6m0.43% | Unchanged |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| CYMABAY THERAPEUTICS INC CBAY | $26.6m3.0m shares |
| VIRIDIAN THERAPEUTICS INC VRDN | $16.9m663.6k shares |